Weed (BUDZ) Share-based Compensation Growth (1y) (2011 - 2024)
Weed (BUDZ) Share-based Compensation Growth (1y) (2011 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Weed | 2.88 Mn | 2.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -37.78% |
| Dec 31, 2023 | 300.00% |
| Sep 30, 2023 | -154.02% |
| Jun 30, 2023 | -88.38% |
| Mar 31, 2023 | -92.84% |
| Dec 31, 2022 | -89.58% |
| Sep 30, 2022 | 91.49% |
| Jun 30, 2022 | -81.51% |
| Mar 31, 2022 | -54.87% |
| Dec 31, 2021 | -66.81% |
| Sep 30, 2021 | -24.35% |
| Jun 30, 2021 | 247.86% |
| Mar 31, 2021 | -65.46% |
| Dec 31, 2020 | -58.33% |
| Sep 30, 2020 | -99.01% |
| Jun 30, 2020 | -112.35% |
| Mar 31, 2020 | 151.34% |
| Dec 31, 2019 | -95.73% |
| Sep 30, 2019 | 197.53% |
| Jun 30, 2019 | 161.07% |